eRegister's captcha

Supplementary Protection Certificate Details

Print page icon Print this page

Supplementary Protection Certificate (SPC) Summary
SPC No. 2017/044
Date of filing 26/10/2017
Notification of Application Published 29/11/2017
Status Rejected
Notification of Grant Published
Date of Expiry of SPC
Applicant ROCHE GLYCART AG
Wagistrasse 18
8952 Schlieren-Zuerich
SWITZERLAND
Patent Number 2464382
Title of Invention COMBINATION THERAPY OF AN AFUCOSYLATED CD20 ANTIBODY WITH BENDAMUSTINE
Date of Expiry of Patent 11/08/2030
Product Type Medicinal Product
Product Identity Obinutuzumab in combination with Bendamustine
Market AuthorisationIreland  
Authorisation NoEU/1/14/937  
Authorisation Date13/06/2016  
Identity of Product AuthorisedGazyvaro-Obinutuzumab in combination with Bendamustine  
Address for Service FRKelly
Waterways House
Grand Canal Quay
Dublin D02 PD39
IRELAND
Renewal Fees
31/10/2017 Request for grant a Supplementary Protection Certificate filed on 26/10/2017, numbered 2017/044.
08/12/2020 Request for grant of Supplementary Protection Certification No. 2017/044 rejected in respect of Article 10(2) of Regulation (EC) No. 469/2009
24/03/2021 Written grounds of decision issued on 19 January 2021.